无症状糖尿病患者中正电子发射断层显像异常的发生率及预后意义
该研究连续纳入2730例无已知冠心病或心肌病的糖尿病患者,行铷-82静息/负荷PET心肌灌注显像并随访全因死亡,中位随访3年。其中无症状者占23.7%,其缺血发生率30.5%、MBFR降低62.3%、冠状动脉微血管功能障碍32.7%;校正分析显示MBFR降低和射血分数降低是无症状患者死亡的独立预后因素,而缺血不是。结论认为无论有无症状,糖尿病患者MBFR受损均常见且与死亡风险升高相关。
要点
- 无症状糖尿病患者中MBFR降低占62.3%,缺血占30.5%,提示PET可检出大量亚临床异常。
- 无症状患者MBFR每降低0.1单位,死亡HR为1.08(95%CI 1.03-1.12,P=0.001)。
- 无症状患者射血分数每降低5%,死亡HR为1.10(95%CI 1.01-1.18,P=0.02)。
核心结论
- 在有症状和无症状糖尿病患者中,MBFR受损均常见且与更高的死亡风险相关;无症状患者中MBFR降低和射血分数降低为死亡的独立预后因素,而缺血不是。
研究设计与样本
- 研究纳入2010至2016年连续2730例无已知冠心病或心肌病的糖尿病患者,均行铷-82静息/负荷PET心肌灌注显像,随访全因死亡(n=461),中位随访3年。
诊断标准与关键数值
- 无症状定义为未引出胸痛或呼吸困难。
- 无症状糖尿病患者(23.7%,n=647)中缺血占30.5%(n=197),MBFR降低占62.3%(n=361),冠状动脉微血管功能障碍占32.7%(n=200)。
- 校正分析中,无症状患者MBFR每降低0.1单位死亡HR为1.08(95%CI 1.03-1.12,P=0.001),射血分数每降低5%死亡HR为1.10(95%CI 1.01-1.18,P=0.02)。
- 无症状患者中缺血与死亡无独立预后关联。
临床应用与阅片要点
- 作者结论认为,在无症状和有症状糖尿病患者中MBFR受损均常见且与更高死亡风险相关。
- 无症状糖尿病患者中,胰岛素使用和年龄较大是MBFR降低的显著预测因素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Ischemia and reduced global myocardial blood flow reserve (MBFR) are associated with high cardiovascular risk among symptomatic patients with diabetes mellitus (DM).
OBJECTIVES: This study aimed to assess the prevalence and prognostic importance of silent ischemia and reduced MBFR among asymptomatic patients with DM.
METHODS: This study included 2,730 consecutive patients with DM, without known coronary artery disease (CAD) or cardiomyopathy, who underwent rubidium-82 rest/stress positron emission tomography (PET) myocardial perfusion imaging (MPI) from 2010 to 2016. These patients were followed up for all-cause mortality (n = 461) for a median follow-up of 3 years. Patients were considered asymptomatic if neither chest pain nor dyspnea was elicited. Rates of ischemia, reduced MBFR, and coronary microvascular dysfunction on PET were assessed in both groups. Cox regression was used to define the independent association of abnormal MPI markers with mortality.
RESULTS: One-quarter of patients with DM (23.7%; n = 647) were asymptomatic; ischemia was present in 30.5% (n = 197), reduced MBFR in 62.3% (n = 361), and coronary microvascular dysfunction in 32.7% (n = 200). In adjusted analyses, reduced MBFR (HR per 0.1 unit decrease in MBFR: 1.08 [95% CI: 1.03-1.12]; P = 0.001) and reduced ejection fraction (HR per 5% decrease: 1.10 [95% CI: 1.01-1.18]; P = 0.02) were independently prognostic of mortality among asymptomatic patients, but ischemia was not. This was comparable to DM patients with symptoms. Insulin use and older age were significant predictors of reduced MBFR among asymptomatic patients with DM.
CONCLUSIONS: In both symptomatic and asymptomatic patients with DM, impairment in MBFR is common and associated with greater mortality risk.
引用
- Patel KK, Singh A, Peri-Okonny PA, et al. Prevalence and Prognostic Importance of Abnormal Positron Emission Tomography Among Asymptomatic Patients With Diabetes Mellitus. JACC Cardiovasc Imaging. 2023. PMID: 37855795. doi:10.1016/j.jcmg.2023.08.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。